Evolutionary Genomics
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-79.94-1.87K-42.88-17.86-10.90-1.33-11.12-3.77-1.51-1.99-2.12-10.90
Price/Sales ratio
N/A146.4146.6592.90179.9212.8071.91517.60N/AN/AN/A12.80
Price/Book Value ratio
-19.95-3.72K4.2011.184.193.64-26.43-3.54-0.93-2.86-0.733.64
Price/Cash Flow ratio
-116.92-1.97K-20.78-18.60-4.99-1.96-14.09-2.81-2.60-7.01-6.42-1.96
Price/Free Cash Flow ratio
-116.92-1.96K-20.78-17.01-4.99-1.96-14.09-2.81-2.60-7.01-6.42-1.96
Price/Earnings Growth ratio
-5.1919.55-0.04-0.070.20-0.010.35-0.03-0.020.08-0.01-0.01
Dividend Yield
N/AN/AN/A954.74%4.12%16.48%N/AN/AN/AN/AN/A16.48%
Profitability Indicator Ratios
Gross Profit Margin
N/A92.95%44.25%100%100%100%-67.76%85.64%N/AN/AN/A100%
Operating Profit Margin
N/A-7.04%-274.93%-475.42%-3984.78%-728.83%-631.55%-23038.36%N/AN/AN/A-3984.78%
Pretax Profit Margin
N/A-7.79%-108.77%-519.90%-3272.72%-956.86%-620.47%-21593.88%N/AN/AN/A-3272.72%
Net Profit Margin
N/A-7.79%-108.77%-519.90%-1650.70%-956.86%-646.47%-13695.06%N/AN/AN/A-1650.70%
Effective Tax Rate
-24.17%-9.56%169.06%-8.55%49.56%23.83%-4.19%36.57%3.00%N/AN/A23.83%
Return on Assets
-1943.49%-1.99%-9.01%-17.99%-9.99%-25.03%-18.69%-42.87%-92.42%-95.51%-82.20%-25.03%
Return On Equity
24.95%198.50%-9.80%-62.56%-38.44%-272.21%237.66%93.75%61.58%143.35%38.85%-38.44%
Return on Capital Employed
18.86%-1.82%-24.78%-16.57%-24.17%-19.06%-18.34%-72.18%-98.78%-92.59%-92.59%-19.06%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A3.92N/A
Quick Ratio
0.0077.212.1948.14112.12N/A8.2387.7313.553.923.67N/A
Cash ratio
0.0033.610.0144.6682.72N/A2.3468.2111.343.233.23N/A
Days of Sales Outstanding
N/A42.6122.4115.30N/A128.5520.36N/AN/AN/AN/A128.55
Days of Inventory outstanding
N/A-4.01K-641.71N/AN/AN/A-73.93N/AN/AN/AN/AN/A
Operating Cycle
N/A-3.97K-619.29N/AN/AN/A-53.57N/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/A348.25N/AN/AN/A34.42644.046.6263.68N/AN/A
Cash Conversion Cycle
N/A-3.97K-967.54N/AN/AN/A-88.00-644.04N/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/A0.561.271.593.37N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/A-1.22-0.85-2.38-1.42N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A5.34-5.701.72-2.02N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A5.34-5.701.72N/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/A-1.02-0.42-0.17N/AN/A
Company Equity Multiplier
-0.01-99.351.083.473.8410.87-12.71-2.18-0.66-1.50-0.4210.87
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/A-0.07-2.24-4.99-36.01-6.52-5.10-183.78N/AN/AN/A-36.01
Free Cash Flow / Operating Cash Flow Ratio
11.0011.09111111.0011
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A-1.02-0.42-0.17N/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/A-17061.18%-44.91%-22.06%N/AN/AN/AN/AN/A-44.91%